Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P000006/S071

Titan Inflatable Penile Prosthesis

Coloplast Corp. · Decision date Aug 14, 2025

FDA DECISIONP000006/S071

What did the FDA approve?

FDA records P000006/S071 as a supplement to PMA P000006, with the supplement type “Real-Time Process”. The recorded decision is approval, dated Aug 14, 2025.

FDA approval order statement

approval for modifications to the True Lock components in the Titan Assembly Kit and True Lock Plug, and a new pouch sealer.
Regulatory pathway
PMA supplement
Supplement type
Real-Time Process
Clinical specialty
Gastroenterology, Urology
Decision date
Aug 14, 2025
FDA change category
Change Design/Components/Specifications/Material

FDA source record

Regulatory record facts

Identifier
P000006/S071
Regulatory pathway
PMA supplement
Product code
FHW
Decision code
APPR
Decision date
Aug 14, 2025
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Device, impotence, mechanical/hydraulic.

Product code
FHW
FDA device class
3

Review the original FDA PMA listing for the original approval scope and linked supplements.

FDA decision timeline

  1. P000006/S071 received

    Application receipt date recorded by FDA.

  2. P000006/S071 · FDA decision

    Real-Time Process

  3. P000006/S072 · Related supplement

    Titan Inflatable Penile Prosthesis (IPP)

  4. P000006/S075 · Related supplement

    Titan Inflatable Penile Prosthesis

  5. P000006/S074 · Related supplement

    Titan Inflatable Penile Prosthesis

  6. P000006/S076 · Related supplement

    Titan Inflatable Penile Prosthesis

Timeline entries are records held by MedtechLedger for P000006. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P000006

Product / regulatory recordCompanyPathwayDecision dateSource
Coloplast Corp.PMA supplementJun 2, 2026FDA
Coloplast Corp.PMA supplementJul 20, 2026FDA
Coloplast Corp.PMA supplementJul 21, 2026FDA
Coloplast Corp.PMA supplementAug 13, 2026FDA

Explore the linked device profile

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

FDA describes the real-time supplement process as a review route for minor changes to a device, including certain design, software, sterilization or labeling changes.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Coloplast Corp.

Headquarters
Not reported
Brand website
coloplast.com
FDA applicant address
1601 W. River Rd. N., Plymouth, MN, 55411

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records